CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (unaudited) - USD ($) $ in Millions	Total	Common Stock	Capital in Excess of Par Value	Treasury Stock	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance at Dec. 31, 2023	$ 4,113	$ 1	$ 695	$ (819)	$ (299)	$ 4,535
Beginning balance (in shares) at Dec. 31, 2023		126,090,000.000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Loss	(132)					(132)
Other comprehensive income	5				5
Common stock repurchase (in shares)		(561,000)
Common stock repurchase	(21)			(21)
Stock-based compensation	15		15
Stock issued under stock plans (in shares)		177,000
Stock issued under stock plans	(3)		(3)
Ending balance at Mar. 31, 2024	3,977	$ 1	707	(840)	(294)	4,403
Ending balance (in shares) at Mar. 31, 2024		125,706,000
Beginning balance at Dec. 31, 2024	$ 4,372	$ 1	811	(1,131)	(239)	4,930
Beginning balance (in shares) at Dec. 31, 2024	123,119,199	123,119,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Loss	$ (166)					(166)
Other comprehensive income	5				5
Common stock repurchase (in shares)		(1,766,000)
Common stock repurchase	(107)			(107)
Stock-based compensation (in shares)		5,000.000
Stock-based compensation	22		22
CARES Act warrants exercised		810,000
Stock issued under stock plans (in shares)		717,000
Stock issued under stock plans	11		11
Ending balance at Mar. 31, 2025	$ 4,137	$ 1	$ 844	$ (1,238)	$ (234)	$ 4,764
Ending balance (in shares) at Mar. 31, 2025	122,884,518	122,885,000